North China Pharmaceutical Company.Ltd (SHA:600812)
China flag China · Delayed Price · Currency is CNY
5.58
+0.04 (0.72%)
Feb 3, 2026, 3:00 PM CST

SHA:600812 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,6051,660988.281,6835,3054,908
Cash & Short-Term Investments
1,6051,660988.281,6835,3054,908
Cash Growth
-6.77%68.00%-41.27%-68.28%8.10%268.76%
Accounts Receivable
2,7732,2922,0662,4262,0461,831
Other Receivables
1,4081,4991,9531,9342,6202,603
Receivables
4,1803,7914,0194,3604,6674,435
Inventory
2,2532,5112,6082,5232,3922,453
Other Current Assets
297.81297.44402.34416.92348.74316.19
Total Current Assets
8,3378,2598,0188,98312,71212,111
Property, Plant & Equipment
6,9667,2037,4737,8698,2518,503
Long-Term Investments
1,2461,2051,220917.98875.9599.42
Goodwill
--3.343.343.343.34
Other Intangible Assets
2,8472,7561,9751,6501,3441,237
Long-Term Deferred Tax Assets
72.4372.4352.1150.2745.0343.55
Long-Term Deferred Charges
2,0691,9182,1571,6881,6391,434
Other Long-Term Assets
-58.5558.5558.758.83-
Total Assets
21,53721,47120,95721,22124,93023,932
Accounts Payable
2,1992,2952,4902,7832,8912,600
Accrued Expenses
206.03202.93200.38238.11299.84265.4
Short-Term Debt
6,6207,0955,4685,2767,6276,826
Current Portion of Long-Term Debt
2,185448.191,0372,9302,323-
Current Portion of Leases
-184.3262.95300.15199.12-
Current Income Taxes Payable
55.7316.0234.5846.4237.2729.61
Current Unearned Revenue
167.62281.75313.25295.87257.75268.58
Other Current Liabilities
976.32438.25462.89540.12604.851,764
Total Current Liabilities
12,41010,96210,26912,40914,24011,753
Long-Term Debt
2,1813,4594,0812,1293,3014,618
Long-Term Leases
149.77263.53299.16413.39326.74-
Long-Term Unearned Revenue
85.2774.0236.8140.0644.4448.57
Long-Term Deferred Tax Liabilities
29.129.1----
Other Long-Term Liabilities
8.329.740.90.90.9456.42
Total Liabilities
14,86314,79714,68614,99317,91316,876
Common Stock
1,7161,7161,7161,7161,7161,631
Additional Paid-In Capital
3,8703,8623,8993,8863,8863,978
Retained Earnings
-89.74-196.77-306.61-311.5480.68510.19
Comprehensive Income & Other
9.438.267.049.52.945.77
Total Common Equity
5,5055,3895,3155,3006,0856,124
Minority Interest
1,1691,285955.11928.25931.75931.24
Shareholders' Equity
6,6746,6756,2706,2287,0177,056
Total Liabilities & Equity
21,53721,47120,95721,22124,93023,932
Total Debt
11,13611,45011,14811,04913,77711,443
Net Cash (Debt)
-9,531-9,790-10,159-9,366-8,472-6,536
Net Cash Per Share
-5.52-5.70-6.23-5.46-4.98-4.03
Filing Date Shares Outstanding
1,7161,7161,7161,7161,7161,716
Total Common Shares Outstanding
1,7161,7161,7161,7161,7161,631
Working Capital
-4,073-2,702-2,251-3,426-1,528357.96
Book Value Per Share
3.213.143.103.093.553.76
Tangible Book Value
2,6582,6333,3373,6464,7384,884
Tangible Book Value Per Share
1.551.531.952.132.762.99
Buildings
-4,4054,3574,2824,011-
Machinery
-7,5496,8046,7446,416-
Construction In Progress
-381.14162.35154.67672.47-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.